OncoTherapy Science (4564) · RiskRestated
Risk of disputes over compensation for employee inventions
First written in FY2017. 1 of 2 entries say "Restated". Latest entry: FY2018.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Risk of costs associated with patent ownership and inventor compensationA theme 8 companies write about · 8 as a headwind · 0 as a tailwind
6 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2018RestatedAnnual report
「As a potential risk, the company cannot rule out the possibility of future disputes over the reasonableness of compensation for rights.」
The company continues to disclose the risk of future disputes over compensation relating to employee inventions. - FY2017First statedAnnual report
「Although no issues have arisen with inventors to date regarding the payment of compensation, the company cannot rule out the possibility of future disputes over the reasonableness of compensation for rights as a potential risk.」
The company has disclosed the possibility of future disputes over compensation for the right to obtain patents for employee inventions.